Issue 4 2024
-
New ATS President Shares Her Vision for the Society in 2024-2025
Irina Petrache, MD, ATSF, an ATS member since 1997, was named the Society’s president for the 2024-2025 term. Dr. Petrache spoke with ATS Conference News to discuss her career, role models, and vision for the ATS under her leadership.
-
Speakers Outline Importance of Individual, Large-Scale Mentorship Efforts at the ATS Women’s Forum
Mentorship has played a vital role in elevating the work of women in pulmonary, critical care, and sleep medicine positions worldwide, and continued efforts are needed to enact lasting change in the field, speakers emphasized during the annual ATS Women’s Forum.
-
Respiratory Health Awards Honor J. Burns Amberson, Trudeau, and Distinguished Achievement Award Winners
The Respiratory Health Awards ceremony at the ATS 2024 International Conference acknowledged four winners of the Society’s most distinguished annual honors. The event included remarks from this year’s J. Burns Amberson, Trudeau Medal, and Distinguished Achievement Award winners.
-
Monday Keynote Speaker Shares Gripping Story of Modern Medical Innovation Amid Polio Epidemic
Many people don’t know about the wide-ranging impacts of the polio epidemic during the 1950s on modern medicine, such as the critical innovation of intensive care units that have become foundational in thoracic medicine. Hannah Wunsch, MD, MSc, described the legacy of polio in medicine and the relatively unknown connections between the disease and the…
-
Don’t Miss the Final Day of the Exhibit Hall and Best of Show Winners
Tuesday is the final day to visit the ATS 2024 Exhibit Hall. International Conference attendees are encouraged to visit with industry leaders and more than 260 booths on the show floor, including the winners of the Best of Show exhibitor contest. The Exhibit Hall is open from 10:30 a.m.-3:30 p.m. PT in the San Diego…
-
Researchers Present Late-Breaking Trial Results with Potential to Impact Clinical Practices
New data for the use of patient-reported outcomes (PRO) in patients with Mycobacterium Avium Complex Lung Disease (MACLD) and two monoclonal antibodies in the treatment of chronic obstructive lung disease (COPD) were presented during Monday’s Clinical Trials Symposium at the ATS 2024 International Conference. The symposium highlighted novel trial results with the potential for great…
-
Final Pediatric Clinical Core Curriculum Session To Focus on Management of the Pediatric Patient with a Tracheostomy
The Pediatric Clinical Core Curriculum wraps at ATS 2024 in San Diego on Wednesday, May 21. The theme for this year’s program is exploring the pulmonologist’s role in the PICU. The final day’s presentations discuss important considerations regarding the care of patients with tracheostomies.